Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Javle

Showing results (41-50 of 343) with videos related to

Pageof 35
Sort By:
Annals of the Royal College of Surgeons of England|May 7, 2009
Prostate abscess: a rare complication of brachytherapy for prostate cancerPaul E Gilmore, Andrew D Baird, Pradip M Javle
Expert Review of Gastroenterology & Hepatology|October 12, 2010
Cholangiocarcinoma: an endoscopist's perspectiveMuslim Atiq, Milind Javle, Shyam Dang, et al.
BJU International|March 11, 2004
The benefits of radical prostatectomy beyond cancer control in symptomatic men with prostate cancerV Kumar, H Toussi, C Marr, et al.
Oncology (Williston Park, N.Y.)|January 15, 2005
Hypersensitivity Reactions to oxaliplatin: incidence and managementAruna Gowda, Ramil Goel, Joanne Berdzik, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 24, 2009
Single nucleotide polymorphisms of gemcitabine metabolic genes and pancreatic cancer survival and drug toxicityTaro Okazaki, Milind Javle, Motofumi Tanaka, et al.
Journal of Endourology|February 1, 2007
Spectroscopic view of life and work of the Nobel Laureate Sir C.V. RamanAmrith Raj Rao, V Hanchanale, P Javle, et al.
Anticancer Research|August 6, 2005
Chemoradiation is a tolerable therapy for older adults with esophageal cancerSujatha Nallapareddy, Gregory E Wilding, Gary Yang, et al.
International Journal of Cancer|December 4, 2004
Nuclear or cytoplasmic expression of survivin: what is the significance?Fengzhi Li, Jie Yang, Nithya Ramnath, et al.
Cancers|July 2, 2021
FGFR Inhibitors in Oncology: Insight on the Management of Toxicities in Clinical PracticeAnuhya Kommalapati, Sri Harsha Tella, Mitesh Borad, et al.
Hematology/Oncology Clinics of North America|June 10, 2026
Molecularly Guided Therapy in Hepatobiliary Cancers: Current Standards and Emerging HorizonsJorge Adeva, Valerie S Kalluri, Fen Saj, et al.
Pageof 35

Showing results (41-50 of 343) with videos related to

Sort By:
Pageof 35
Annals of the Royal College of Surgeons of England|May 7, 2009
Prostate abscess: a rare complication of brachytherapy for prostate cancerPaul E Gilmore, Andrew D Baird, Pradip M Javle
Expert Review of Gastroenterology & Hepatology|October 12, 2010
Cholangiocarcinoma: an endoscopist's perspectiveMuslim Atiq, Milind Javle, Shyam Dang, et al.
BJU International|March 11, 2004
The benefits of radical prostatectomy beyond cancer control in symptomatic men with prostate cancerV Kumar, H Toussi, C Marr, et al.
Oncology (Williston Park, N.Y.)|January 15, 2005
Hypersensitivity Reactions to oxaliplatin: incidence and managementAruna Gowda, Ramil Goel, Joanne Berdzik, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 24, 2009
Single nucleotide polymorphisms of gemcitabine metabolic genes and pancreatic cancer survival and drug toxicityTaro Okazaki, Milind Javle, Motofumi Tanaka, et al.
Journal of Endourology|February 1, 2007
Spectroscopic view of life and work of the Nobel Laureate Sir C.V. RamanAmrith Raj Rao, V Hanchanale, P Javle, et al.
Anticancer Research|August 6, 2005
Chemoradiation is a tolerable therapy for older adults with esophageal cancerSujatha Nallapareddy, Gregory E Wilding, Gary Yang, et al.
International Journal of Cancer|December 4, 2004
Nuclear or cytoplasmic expression of survivin: what is the significance?Fengzhi Li, Jie Yang, Nithya Ramnath, et al.
Cancers|July 2, 2021
FGFR Inhibitors in Oncology: Insight on the Management of Toxicities in Clinical PracticeAnuhya Kommalapati, Sri Harsha Tella, Mitesh Borad, et al.
Hematology/Oncology Clinics of North America|June 10, 2026
Molecularly Guided Therapy in Hepatobiliary Cancers: Current Standards and Emerging HorizonsJorge Adeva, Valerie S Kalluri, Fen Saj, et al.
Pageof 35